• CCO
• Hepatitis
• Live Events
• Management of Hepatocellular Carcinoma

Golden Gate A & B
San Francisco Marriott
San Francisco, California

Thank you for your interest in this live program. Registration is closed, as the current schedule has been completed. Please email info@clinicaloptions.com for more information.

This independent satellite symposium will provide clinicians with updated information on clinical practice guidelines, practical therapeutic applications of targeted agents, and ongoing research to expand the treatment armamentarium for the treatment of patients with hepatocellular carcinoma.

Presented for attendees of the 59th AASLD Annual Meeting. This is not an official function/event of the American Association for the Study of Liver Diseases.

• Agenda
• Faculty
• CME Information
• Accreditation

Event Date	Details
Monday, November 03, 2008	6:30 PM - 8:30 PM Local Time 6:30 PM - 7:00 PM Registration and Reception 7:00 PM - 8:30 PM Symposium

Agenda

Welcome and Introduction
Program Director
Jordi Bruix, MD

What Do the AASLD Guidelines Tell Us and How Are They Applied in Clinical Practice?
Program Director
Jordi Bruix, MD

The NCCN Guideline Recommendations and Novel Agents in HCC
Alan P. Venook, MD

Consensus Guidelines for Research in HCC: Future Perspectives and Novel Agents
Riccardo Lencioni, MD

Future Research Topics and Opportunities: The Consolidation of Molecular Medicine
Adrian M. Di Bisceglie, MD, FACP

Question and Answer Session

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC